FORTREA HOLDINGS INC (FTRE) Stock Price, Quote, News and Overview
NASDAQ:FTRE - Nasdaq - US34965K1079 - Common Stock - Currency: USD
FTRE Quote, Performance and Key Statistics
FORTREA HOLDINGS INC
NASDAQ:FTRE (2/7/2025, 8:00:01 PM)
After market: 14.91 0 (0%)14.91
-0.49 (-3.18%)
The current stock price of FTRE is 14.91 USD. In the past month the price decreased by -19.01%. In the past year, price decreased by -53.11%.
FTRE Latest News and Analysis
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today...
Critical Insights From Fortrea Holdings Analyst Ratings: What You Need To Know
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman
Fortrea to Present at the Evercore HealthCONx Conference
Fortrea to Present at the Citi Global Healthcare Conference
FTRE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.14 | 218.59B | ||
| DHR | DANAHER CORP | 27.6 | 149.34B | ||
| A | AGILENT TECHNOLOGIES INC | 27.45 | 41.41B | ||
| IQV | IQVIA HOLDINGS INC | 18.68 | 37.78B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.77 | 29.33B | ||
| WAT | WATERS CORP | 35.95 | 24.32B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 47.57 | 23.29B | ||
| ILMN | ILLUMINA INC | 45.33 | 17.61B | ||
| ICLR | ICON PLC | 13.79 | 15.97B | ||
| RVTY | REVVITY INC | 24.26 | 14.47B | ||
| AVTR | AVANTOR INC | 19.16 | 13.04B | ||
| TECH | BIO-TECHNE CORP | 40.23 | 11.57B |
Related stock screener links
About FTRE
Company Profile
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 15,500 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Company Info
FORTREA HOLDINGS INC
8 Moore Drive
Durham NORTH CAROLINA US
Employees: 16000
Company Website: https://www.fortrea.com/
Phone: 18774950816
FTRE FAQ
What is the stock price of FTRE?
The current stock price of FTRE is 14.91 USD.
What is the symbol for FORTREA HOLDINGS INC stock?
The exchange symbol of FORTREA HOLDINGS INC is FTRE and it is listed on the Nasdaq exchange.
On which exchange is FTRE stock listed?
FTRE stock is listed on the Nasdaq exchange.
Is FTRE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for FTRE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of FTRE.
Does FTRE stock pay dividends?
FTRE does not pay a dividend.
When does FTRE stock report earnings?
FTRE will report earnings on 2025-03-03, before the market open.
What is the Price/Earnings (PE) ratio of FTRE?
The PE ratio for FTRE is 42.6. This is based on the reported non-GAAP earnings per share of 0.35 and the current share price of 14.91 USD.
What is the Short Interest ratio of FTRE stock?
The outstanding short interest for FTRE is 6.62% of its float.
FTRE Technical Analysis
FTRE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to FTRE. FTRE may be in some trouble as it scores bad on both profitability and health.
FTRE Financial Highlights
Over the last trailing twelve months FTRE reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS decreased by -232.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.28% | ||
| ROE | -20.04% | ||
| Debt/Equity | 0.74 |
FTRE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 53% to FTRE. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -60.59% and a revenue growth -13.08% for FTRE